about
Outcome of infections due to pandrug-resistant (PDR) Gram-negative bacteriaToxicity after prolonged (more than four weeks) administration of intravenous colistinWorldwide trends in quantity and quality of published articles in the field of infectious diseasesWorldwide research productivity in critical care medicine.Home versus ambulatory and office blood pressure in predicting target organ damage in hypertension: a systematic review and meta-analysis.Do high doses of quinolones decrease the emergence of antibacterial resistance? A systematic review of data from comparative clinical trials.A bibliometric analysis of research productivity in Parasitology by different world regions during a 9-year period (1995-2003)Attributable mortality of Acinetobacter baumannii infections in critically ill patients: a systematic review of matched cohort and case-control studies.Unusual climatic conditions and infectious diseases: observations made by Hippocrates.Home blood pressure monitoring in the diagnosis and treatment of hypertension: a systematic review.Impact of definitive therapy with beta-lactam monotherapy or combination with an aminoglycoside or a quinolone for Pseudomonas aeruginosa bacteremia.The diversity of definitions of multidrug-resistant (MDR) and pandrug-resistant (PDR) Acinetobacter baumannii and Pseudomonas aeruginosa.Ciprofloxacin vs an aminoglycoside in combination with a beta-lactam for the treatment of febrile neutropenia: a meta-analysis of randomized controlled trials.Quinolones for treatment of human brucellosis: critical review of the evidence from microbiological and clinical studies.The role of aminoglycosides in combination with a beta-lactam for the treatment of bacterial endocarditis: a meta-analysis of comparative trials.Spondylodiscitis after facet joint steroid injection: a case report and review of the literature.Ciprofloxacin/metronidazole versus beta-lactam-based treatment of intra-abdominal infections: a meta-analysis of comparative trials.Intraventricular or intrathecal use of polymyxins in patients with Gram-negative meningitis: a systematic review of the available evidence.Impact of initial discordant treatment with beta-lactam antibiotics on clinical outcomes in adults with pneumococcal pneumonia: a systematic review.Eighteen years of research on AIDS: contribution of and collaborations between different world regions.Pandrug-resistant Gram-negative bacteria: the dawn of the post-antibiotic era?Oral rifampin for eradication of Staphylococcus aureus carriage from healthy and sick populations: a systematic review of the evidence from comparative trials.Trends in the methodological quality of published randomized controlled trials on antibacterial agentsAntibiotic-lock therapy for long-term catheter-related bacteremia: a review of the current evidence.Outcomes after medical and surgical treatment of diverticulitis: a systematic review of the available evidence.Albendazole for the treatment of human echinococcosis: a review of comparative clinical trials.Comparison of utility of blood cultures from intravascular catheters and peripheral veins: a systematic review and decision analysis.Daptomycin versus other antimicrobial agents for the treatment of skin and soft tissue infections: a meta-analysis.β-Lactam plus aminoglycoside or fluoroquinolone combination versus β-lactam monotherapy for Pseudomonas aeruginosa infections: a meta-analysis.Estimates of global research productivity in virology.A bibliometric analysis of global trends of research productivity in tropical medicine.A bibliometric analysis by geographic area of published research in several biomedical fields, 1995-2003.Role of glycopeptides as part of initial empirical treatment of febrile neutropenic patients: a meta-analysis of randomised controlled trials.Administration of antibiotics via the respiratory tract for the prevention of ICU-acquired pneumonia: a meta-analysis of comparative trials.Case-control studies reporting on risk factors for emergence of antimicrobial resistance: bias associated with the selection of the control group.Effect of aminoglycoside and beta-lactam combination therapy versus beta-lactam monotherapy on the emergence of antimicrobial resistance: a meta-analysis of randomized, controlled trials.Thrombotic microangiopathy associated with gemcitabine: rare but real.Science in Greece: from the age of Hippocrates to the age of the genome.A prospective study of services utilization of a hospital-based employee health clinic.Oral rifampin for prevention of S. aureus carriage-related infections in patients with renal failure--a meta-analysis of randomized controlled trials.
P50
Q24794555-9A7CB36A-0DD9-41C4-993E-A95F21B1B801Q24798835-8139ADAC-BDBB-4FF8-A2B2-2FC732048150Q24811662-1F36C6ED-8AEB-49BF-89C6-4E29638904A2Q24811739-7AA11DB9-25FE-4917-B895-E03329430679Q31054761-6BD47816-A13F-4D4D-A8C5-9FFA32853D1AQ31113575-EB8FBD4F-32E6-4882-B197-5394542622FCQ33236888-53B1055B-00D2-4A7E-819F-AA12F5303611Q33237577-F914B707-528A-42C1-83F5-C87A8904E8C9Q33577655-D68D8E1B-22D7-4CD2-BBBB-C04C317B1065Q33715998-8BB89376-9C42-4C70-9B33-5E4D7D707AFEQ34064473-E91B6342-6268-46E6-9731-62040E0AAEE3Q34581987-4F64CB6E-7ED6-44C6-A434-017A862FB8F9Q36264410-BE53A605-F8F8-4D24-9A53-CCBE7C9EA7B3Q36353529-9F04FC09-2156-43C6-B8AF-7FAC095B1F94Q36406309-558C5998-6D8A-4E7A-8E7E-1EE84612768CQ36485852-5428F7E5-ACB2-4751-B3DD-12E9AE84EC1AQ36561300-C2B8071C-9BCD-4334-8395-6225AE4D84A3Q36663425-6F9F0EB8-D110-423E-8704-C39468B1A0DDQ36682228-101EB539-328E-464D-8C59-02E9418DDB48Q36702107-7EE389DC-C61F-41B1-B6D8-F444D91175BEQ36738598-D1241B89-E41F-4CD4-9664-565FCA44EA97Q36746970-3609FBA4-B529-4B33-8DBE-F3E47FA517F4Q36792671-15B5B8E4-F1F6-4EA5-A60A-236FDFACC0E4Q36901951-30C440B7-A004-47DA-9BD5-C16FC0F01CB9Q36918234-1A386413-A499-484F-9CB7-43981381D10FQ36943449-B3829A4A-24E9-4180-AF9D-6099D80E896DQ37027087-528CD022-E8E2-4735-85A0-F7882AB520B2Q37637758-F9EA5047-A9FC-4373-997D-C00E13D73727Q38081609-E09C5EC8-4A6D-443D-8EF0-FD6960178020Q38458298-5D6C88CA-D7A3-434B-862D-C012F581F815Q38998172-1F7B76BC-3C3D-4642-A4E9-4A143DFA3CD6Q39095889-65312188-441D-4746-90A2-337B3D955925Q40505256-C1440A6B-D899-4C80-BBCF-6B621C4E202AQ42094286-B3FD2FE6-6BF7-4FF6-AE07-7B2BE3A891FFQ43534047-1E64D420-5895-46C8-BAA7-3A0C6E3A1CEFQ44023944-94798AA9-F2CA-450E-A731-6B832C822B5CQ45978337-130E7FF9-3095-4D51-8132-3FB922122F1DQ47184030-A5466018-8439-4075-A88D-90ACA8EE9031Q50106773-207F211A-D264-4EF6-B661-4B451A66FC39Q50111006-71E38EC2-B2BD-447E-9289-49C27CD6F36B
P50
name
Ioannis A Bliziotis
@en
type
label
Ioannis A Bliziotis
@en
prefLabel
Ioannis A Bliziotis
@en